Search research articles
Contact Us
Filters
Showing results (171-180 of 184) with videos related to
Page
of 19
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
NPJ Precision Oncology
|
July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2024
<i>CCR5</i> and <i>CCL5</i> gene expression in colorectal cancer: comprehensive profiling and clinical value
Francesca Battaglin, Yasmine Baca, Joshua Millstein, et al.
JCO Oncology Advances
|
May 7, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations
Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura, et al.
Frontiers in Molecular Neuroscience
|
November 2, 2017
Tunneling Nanotubes and Gap Junctions-Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions
Jennifer Ariazi, Andrew Benowitz, Vern De Biasi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2024
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
Hiroyuki Arai, Yan Yang, Yasmine Baca, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?
Paul W Sperduto, Penny Fang, Jing Li, et al.
The Lancet. Oncology
|
May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
Emil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Paul W Sperduto, Penny Fang, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 25, 2022
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors
Paul W Sperduto, Brian De, Jing Li, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 184) with videos related to
Sort By:
Page
of 19
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
NPJ Precision Oncology
|
July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2024
<i>CCR5</i> and <i>CCL5</i> gene expression in colorectal cancer: comprehensive profiling and clinical value
Francesca Battaglin, Yasmine Baca, Joshua Millstein, et al.
JCO Oncology Advances
|
May 7, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations
Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura, et al.
Frontiers in Molecular Neuroscience
|
November 2, 2017
Tunneling Nanotubes and Gap Junctions-Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions
Jennifer Ariazi, Andrew Benowitz, Vern De Biasi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2024
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
Hiroyuki Arai, Yan Yang, Yasmine Baca, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?
Paul W Sperduto, Penny Fang, Jing Li, et al.
The Lancet. Oncology
|
May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
Emil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Paul W Sperduto, Penny Fang, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 25, 2022
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors
Paul W Sperduto, Brian De, Jing Li, et al.
Page
of 19